Astrazeneca (AZN) - News Mentions

Sign up to add (AZN) to your portfolio and access more historical data.

20%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Johnson & Johnson
Johnson & Johnson
JNJ		 1 0%
Eli Lilly and Company
Eli Lilly and Company
LLY		 0 0%
Pfizer
Pfizer
PFE		 2 33.3%
AbbVie
AbbVie
ABBV		 2 100%
TherapeuticsMD
TherapeuticsMD
TXMD		 0 0%
ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
December 20
AstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens Berman
December 19
AstraZeneca PLC Announcement: If You Have Suffered Losses in AstraZeneca PLC (NASDAQ: AZN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 18
Is AstraZeneca PLC (AZN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
December 17
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Verition Fund Management LLC
December 14
Analysts Set AstraZeneca PLC (LON:AZN) Target Price at £104.12
December 13
AstraZeneca’s (AZN) Struggles: Cramer’s Disappointment and Challenges in China
December 10
AZN, Daiichi's ADC Gets FDA Breakthrough Tag for EGFR-Mutated NSCLC
December 9
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
December 9
Astrazeneca Reports Positive Phase 3 Calquence Data for Chronic Lymphocytic Leukemia
December 8
AZN's Bladder Cancer sBLA for Imfinzi Gets FDA's Priority Tag
December 8
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
December 4
The Manufacturers Life Insurance Company Sells 2,033 Shares of AstraZeneca PLC (NASDAQ:AZN)
December 2
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
December 1
Why AstraZeneca PLC (AZN) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
December 1
Why AstraZeneca PLC (AZN) Is One of the Best ADR Stocks to Invest in?
November 30

Month over Month

Est. daily news mentions.

Nov 2024 3
Oct 2024 2
Sep 2024 3
Aug 2024 2
Jul 2024 4

How often is Astrazeneca mentioned in the news?

Astrazeneca was mentioned an estimated 2 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Astrazeneca performing compared to its industry peers?

Astrazeneca underperforms its industry peers when it comes to News Mentions, ranking in the 33rd percentile.

Has there been an increase or decrease in news mentions of Astrazeneca in the last month?

Astrazeneca's was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Astrazeneca?

By monitoring mentions in the news for Astrazeneca, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Astrazeneca, ultimately improving their investment strategies.

Sign up and get more insights on Astrazeneca.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact